Find More Contacts for Selecta Biosciences
Protected Content
CEO, President
Executive Management
1 email found 1 phone number found
View contacts for Selecta Biosciences to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email info@selectabio.com
  • Phone Number (617) 923-1400

Selecta Biosciences is a biopharmaceutical company developing the first generation of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Their proprietary product platform technology combines recent advances in immunobiology with cutting-edge nanotechnology to develop targeted immunomodulatory nanoparticles.

It

was founded in 2008 and is headquartered in Watertown, Massachusetts.

Lists Featuring This Company

Northeastern US Pharmaceutical Companies
2,982 Number of Organizations â€¢ $171.3B Total Funding Amount â€¢ 3,749 Number of Investors
Investors Active in United States (Top 10K)
9,915 Number of Organizations â€¢ $2.1T Total Funding Amount â€¢ 21,595 Number of Investors
East Coast Biopharma Companies
702 Number of Organizations â€¢ $38.6B Total Funding Amount â€¢ 1,758 Number of Investors
Investors Active in Western US (Top 10K)
9,591 Number of Organizations â€¢ $1.7T Total Funding Amount â€¢ 15,618 Number of Investors
Selecta Biosciences merged with Cartesian Therapeutics on Nov 13, 2023. This deal was done in Cash & Stock.

Frequently Asked Questions

Where is Selecta Biosciences's headquarters? Selecta Biosciences is located in Watertown, Massachusetts, United States.Who invested in Selecta Biosciences? Selecta Biosciences has 20 investors including Timothy A. Springer and Silicon Valley Bank.How much funding has Selecta Biosciences raised to date? Selecta Biosciences has raised .When was the last funding round for Selecta Biosciences? Selecta Biosciences closed its last funding round on Nov 13, 2023 from a Post-IPO Equity round.Who are Selecta Biosciences's competitors? Alternatives and possible competitors to Selecta Biosciences may include ImmunomeArcellx, and KSQ Therapeutics.